Farallon Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-400,000
Closed -$7.1M 110
2018
Q3
$7.1M Buy
+400,000
New +$7.1M 0.04% 86
2013
Q3
Sell
-155,000
Closed -$2.04M 87
2013
Q2
$2.04M Buy
+155,000
New +$2.04M 0.04% 77